Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagenic Therapeutics Inc

3.62
+0.13503.87%
Post-market: 3.650.0300+0.83%19:55 EDT
Volume:95.25K
Turnover:343.48K
Market Cap:3.14M
PE:-0.23
High:3.67
Open:3.54
Low:3.52
Close:3.49
Loading ...
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 02, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 21, 2021

Major Issues Report

8-K - Current report
Apr 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 08, 2021

Major Issues Report

8-K - Current report
Apr 07, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans